Cannabis firm Rua Bioscience targets October NZX listing
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
TVNZ targets one million digital viewers logged in by 2030
The latest performance forecast unfolds the broadcaster’s online ambitions.
Piercing chain SkinKandy making its mark in Kiwi malls
The Australian piercing chain plans to have opened 10 NZ stores by December.
RBNZ likely to hit pause as market eyes future cuts
The official cash rate is at 3.25% versus 5.5% a year ago.
Tough conversations ahead as cost of living drives employee requests for pay rises
Rising living costs put pressure on both workers and employers.
Why corporate giving matters
Dave Letele and Z provide support where urgent need is overlooked.
